MétaCan
Menu
← Back to cohort

Does frailty affect response to chemotherapy in older men with metastatic castration-resistant prostate cancer?

2015· article· en· W2625985775 on OpenAlexaff
Shabbir M.H. Alibhai, Tharsika Manokumar, Salman Aziz, Faraz Rizvi, Henriette Breunis, Anthony M. Joshua

Bibliographic record

VenueJournal of Clinical Oncology · 2015
Typearticle
Languageen
FieldMedicine
TopicFrailty in Older Adults
Canadian institutionsPrincess Margaret Cancer CentreUniversity Health Network
Fundersnot available
KeywordsMedicineProstate cancerGrip strengthQuality of life (healthcare)DocetaxelPerformance statusInternal medicineCancerPhysical therapyGerontologyOncology

Abstract

fetched live from OpenAlex

e20528 Background: There is increasing recognition that frailty, which is common in older adults with cancer, may negatively impact treatment and survival. Few data exist, however, in specific disease settings. We examined the impact of frailty on elder-relevant outcomes in men with metastatic castration-resistant prostate cancer (mCRPC). Methods: Men aged 65+ with mCRPC starting first-line chemotherapy with docetaxel and prednisone were enrolled in an observational study. Frailty was evaluated with the Vulnerable Elders Survey (VES-13) questionnaire. Three main elder-relevant outcomes were assessed: physical function (timed up and go (TUG) test, timed chair stands, and grip strength), functional status (OARS-IADL), and quality of life (QOL, with the FACT-P and FACT-G for prostate-specific and general QOL, respectively). Assessments were completed before each cycle of chemotherapy. Pre-post within-group comparisons were done using student’s T-tests and linear regression, stratified by frailty status. Results: 44 patients (mean age 75) receiving chemotherapy were enrolled, of whom 56% were frail by VES-13. Frail men had worse physical function, functional status, and QOL at baseline than non-frail men (all p < 0.05). From baseline to end-of-study, functional status remained stable and both general and prostate-specific QOL improved in the majority of men. TUG scores and grip strength were stable over time in the majority of men. For all of these outcomes the trajectory was similar among frail and non-frail men. Only timed chair stand performance differed by frailty status over time; non-frail men demonstrated improvement whereas frail men declined by end-of-study. Frailty status at baseline (frail/non-frail) remained stable in the vast majority of men at chemotherapy completion. Conclusions: Contrary to our hypothesis, frail older men with mCRPC had similar changes during docetaxel-based chemotherapy in most areas of physical function, functional status, and QOL compared to non-frail older men. Although chemotherapy appears to be well-tolerated in these men, confirmation in a larger dataset is required. Importantly, the VES-13 may not be a suitable frailty measure in this population.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.004
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.121
GPT teacher head0.482
Teacher spread0.361 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2015
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical Oncology→Same topicFrailty in Older Adults→French-language works237,207→